Prim, S.A. (BME: PRM)
Spain
· Delayed Price · Currency is EUR
9.66
+0.04 (0.42%)
Jan 17, 2025, 5:35 PM CET
Prim, S.A. Revenue
Prim, S.A. had revenue of 119.69M EUR in the half year ending June 30, 2024, with 20.93% growth. This brings the company's revenue in the last twelve months to 227.57M, up 9.85% year-over-year. In the year 2023, Prim, S.A. had annual revenue of 216.62M with 9.74% growth.
Revenue (ttm)
227.57M
Revenue Growth
+9.85%
P/S Ratio
0.72
Revenue / Employee
252.57K
Employees
900
Market Cap
164.38M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 216.62M | 19.22M | 9.74% |
Dec 31, 2022 | 197.40M | 28.82M | 17.10% |
Dec 31, 2021 | 168.57M | 21.16M | 14.35% |
Dec 31, 2020 | 147.41M | -3.66M | -2.42% |
Dec 31, 2019 | 151.07M | 16.64M | 12.38% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grifols | 7.01B |
Laboratorios Farmaceuticos Rovi | 799.25M |
Almirall | 953.49M |
Pharma Mar | 167.00M |
Faes Farma | 504.04M |
Clínica Baviera | 252.47M |
Atrys Health | 211.11M |
Laboratorio Reig Jofre | 333.69M |